FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Novavax Amends Covid Vaccine EUA

[ Price : $8.95]

Novavax files an amendment to its Emergency Use Authorization for an updated JN.1 Covid-19 vaccine (NVX-CoV2705) for individuals a...

Guide on Diabetic Foot Infection Drugs

[ Price : $8.95]

FDA posts a final guidance entitled Diabetic Foot Infections (DFI): Developing Drugs for Treatment.

Amgens Blincyto Gets Expanded Leukemia Use

[ Price : $8.95]

FDA approves an expanded use for Amgens Blincyto (blinatumomab) for treating adult and pediatric patients one month or older with ...

Pfizer Duchene Gene Therapy Fails Phase 3 Study

[ Price : $8.95]

Pfizer says that its Phase 3 CIFFREO placebo-controlled study evaluating an investigational mini-dystrophin gene therapy, fordadis...

Shaver Permanently Debarred by FDA

[ Price : $8.95]

Federal Register notice: FDA issues an order permanently debarring Jonathan R. Shaver from providing services in any capacity to a...

FDA Debars Smith for 5 Years

[ Price : $8.95]

Federal Register notice: FDA issues an order debarring Richard B. Smith III for five years from importing or offering for import a...

Emerging Drug Safety Technology Meeting Program

[ Price : $8.95]

CDER Office of Surveillance and Epidemiology deputy director Robert Ball describes the Emerging Drug Safety Technology Meeting pro...

DSCSA Pilot Project Report Out

[ Price : $8.95]

FDA says it has issued a final report from the Drug Supply Chain Security Act pilot project.

ICH M10 Bioanalytical Method Analysis Q&A Guidance

[ Price : $8.95]

FDA publishes an International Council for Harmonization question-and-answer guidance responding to questions about its M10 bioana...

FDA Accelerated Approval for BMS Augtyro Cancer Drug

[ Price : $8.95]

FDA grants accelerated approval to Bristol Myers Squibbs Augtyro to treat some adults and pediatric patients with neurotrophic tyr...